US6069689A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Apparatus and methods relating to optical systems for diagnosis of skin diseases
Assignee: Derma Technologies Inc
•
Filing: 1998-04-14
•
Granted: 2000-05-30
•
Expires: 2018-04-14
Abstract
Abstract Apparatus for diagnosis of a skin disease site using spectral analysis includes a light source for generating light to illuminate the disease site and a probe unit optically connected to the light source for exposing the disease site to light to generate fluorescence and reflectance light. The probe unit also collects the generated fluorescence and reflectance light and transmits this light to a spectrometer to be analyzed. The spectrometer generates and displays spectral measurements of the fluorescence light and the reflectance light which in together assist the user in diagnosing the disease site. The apparatus makes use of a conventional personal computer using a plug-in spectrometer card to provide a compact and low costs system. The system performs combined fluorescence and reflectance spectral analysis in a quick and efficient manner to provide a powerful tool for dermatologic diagnosis.
Inventors
- 👤 Haishan Zeng
- 👤 Harvey Lui
- 👤 Calum MacAulay
- 👤 Branko Palcic
- 👤 David I. McLean
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 15:26
CPC Classifications
G; G01; G01N; G01N21/00; G01N21/17; G01N21/47; G01N21/4738; G01N21/474; A; A61; A61B; A61B5/00; A61B5/0059; A61B5/0071; A61B5/44; A61B5/441; A61B5/444; G01N21/62; G01N21/63; G01N21/64; G01N21/645; G01N21/6486; G01N21/65; G01N2021/4742; G01N2021/475; G01N2021/6417; G01N2021/653; G01N2021/656; G01N2201/00; G01N2201/06; G01N2201/062; G01N2201/0627
Claims Analysis
Total Claims: 23
Claim 1
Independent Claim
194 words
An optical probe able to induce at least one of fluorescence light, reflectance light and Raman scattering in vivo in a target tissue, the optical probe comprising a proximal end, a distal end, at least one light emitting diode disposed at the distal end of the optical probe and operatively connected to a power source able to provide power to the light emitting diode such that the light emitting diode can emit excitation light able to induce at least one of fluorescence light, reflectance light and Raman scattering in the target tissue, and at least one collection fiber that transmits light from the distal end of the optical probe to the proximal end of the optical probe, the distal end of the optical probe comprising at least one of a plurality of light emitting diodes that emit different wavelengths of excitation light and a plurality of light filters that transmit different wavelengths of excitation light to provide a plurality of light sources, and an on and off switch to switch the light emitting diodes on and off such that the target tissue is illuminated sequentially by one of the light sources at a time.
Claim 2
Dependent Claim
194 words
An optical probe able to induce at least one of fluorescence light, reflectance light and Raman scattering in vivo in a target tissue, the optical probe comprising a proximal end, a distal end, at least one light emitting diode disposed at the distal end of the optical probe and operatively connected to a power source able to provide power to the light emitting diode such that the light emitting diode can emit excitation light able to induce at least one of fluorescence light, reflectance light and Raman scattering in the target tissue, and at least one collection fiber that transmits light from the distal end of the optical probe to the proximal end of the optical probe, the distal end of the optical probe comprising at least one of a plurality of light emitting diodes that emit different wavelengths of excitation light and a plurality of light filters that transmit different wavelengths of excitation light to provide a plurality of light sources, and an on and off switch to switch the light emitting diodes on and off such that the target tissue is illuminated sequentially by one of the light sources at a time.
Claim 3
Dependent Claim
67 words
An optical probe as claimed in claim 1 in which the collection fiber is operatively connected to a spectrometer able to analyze the spectra transmitted by the collection fiber, which spectrometer is operatively connected to a memory readable by a computer that contains a plurality of comparison spectra corresponding to, and able to distinguish between, each of actinic keratosis, seborrheic keratosis, basal cell carcinoma and compound nevus.
Claim 4
Dependent Claim
41 words
An optical probe as claimed in claim 2 further comprising a computer that controls the on and off switch and the spectrometer in order to acquire sequential spectral measurements of at least two of fluorescence light, reflectance light and Raman scattering.
Claim 5
Dependent Claim
32 words
An optical probe as claimed in claim 3 in which the computer comprises a personal computer and the spectrometer comprises a computer interface card installable in an interface slot of the computer.
Claim 6
Dependent Claim
30 words
An optical probe as claimed in claim 4 in which the spectrometer computer interface card includes a miniature monochromator, a CCD linear array detector, and data acquisition and controlling circuitry.
Claim 7
Dependent Claim
28 words
An optical probe as claimed in claim 1 in which the collection light guide comprises a light filter selected to pass fluorescence light and block reflected excitation light.
Claim 8
Dependent Claim
23 words
An optical probe as claimed in claim 1 in which the optical probe is optically connected to the spectrometer by optical fiber bundles.
Claim 9
Dependent Claim
52 words
An optical probe as claimed in claim 1 in which the optical probe comprises an elongate member having an open end defining a chamber with opaque walls that is positionable over the disease site to exclude external light from the chamber, the chamber containing therein the at least one light emitting diode.
Claim 10
Dependent Claim
92 words
An optical probe as claimed in claim 8 in which the elongate member comprises: a generally cylindrical member housing the optical fiber bundles that extend to a distal end of the cylindrical member; and a sleeve member that telescopes over the generally cylindrical housing, the overlap of the sleeve member with the distal end of the cylindrical member defining the chamber wherein slidable movement of the sleeve member with respect to the cylindrical member adjusts the length of the chamber to vary the size of the illumination spot at the disease site.
Claim 11
Dependent Claim
48 words
An optical probe as claimed in claim 9 in which the sleeve member is formed with a window for viewing inside the chamber to ensure proper positioning of the chamber over the disease site and a slidable cover to seal the window when the apparatus is in use.
Claim 12
Dependent Claim
34 words
An optical probe as claimed in claim 1 in which the free end of the sleeve member is cut at substantially 45 degrees to the longitudinal axis of the sleeve to avoid specular reflection.
Claim 13
Independent Claim
101 words
A method for diagnosis of a disease selected from the group consisting of actinic keratosis, seborrheic keratosis, basal cell carcinoma, compound nevus and spider angioma at a skin disease site using spectral analysis comprising the steps of: illuminating the disease site with a light source to generate fluorescence and reflectance light at the disease site; collecting the generated fluorescence light; conducting a spectral analysis of the collected light using a spectrometer; determining spectral measurements of the fluorescence light and therefrom determining a 3-D spectrum of the fluorescence light; and examining the spectral measurements to make a diagnosis of the disease site.
Claim 14
Independent Claim
101 words
A method for diagnosis of a disease selected from the group consisting of actinic keratosis, seborrheic keratosis, basal cell carcinoma, compound nevus and spider angioma at a skin disease site using spectral analysis comprising the steps of: illuminating the disease site with a light source to generate fluorescence and reflectance light at the disease site; collecting the generated fluorescence light; conducting a spectral analysis of the collected light using a spectrometer; determining spectral measurements of the fluorescence light and therefrom determining a 3-D spectrum of the fluorescence light; and examining the spectral measurements to make a diagnosis of the disease site.
Claim 15
Dependent Claim
19 words
A method as claimed in claim 12 including filtering the collected fluorescence light to filter out the excitation light.
Claim 16
Dependent Claim
35 words
A method as claimed in claim 12 in which a spectrometer card mounted in a personal computer is used to conduct a spectral analysis of the generated fluorescence and reflected light and display spectral measurements.
Claim 17
Dependent Claim
29 words
A method as claimed in claim 12 in which the step of collecting the generated fluorescence light involves collecting light from the disease site and the surrounding normal skin.
Claim 18
Dependent Claim
30 words
A method as claimed in claim 15 in which the step of examining the spectral measurements involves comparing the disease site spectrum to the spectrum of the surrounding normal skin.
Claim 19
Dependent Claim
29 words
A method as claimed in claim 16 including the step of generating a ratio spectrum by dividing the disease site spectrum by the spectrum of the adjacent normal skin.
Claim 20
Dependent Claim
38 words
A method as claimed in claim 12 in which the step of determining a 3-D spectrum of the fluorescence light further comprises generating a two-dimensional contour plot from the 3-D spectrum to generate a fluorescence excitation-emission matrix (EEM).
Claim 21
Dependent Claim
40 words
A method as claimed in claim 12 in which the step of determining a 3-D spectrum of the fluorescence light further comprises sectioning the 3-D spectrum at a fixed emission wavelength to generate a 2-D plot of fluorescence excitation spectrum.
Claim 22
Dependent Claim
33 words
A method as claimed in claim 12 in which the method further comprises generating a ratio matrix by dividing a 3-D spectrum from a lesion versus a 3-D spectrum from surrounding normal skin.
Claim 23
Dependent Claim
32 words
A method as claimed in claim 12 in which the method further comprises generating a subtractive matrix by subtracting a 3-D spectrum a lesion from a 3-D spectrum from surrounding normal skin.
References Cited (Backward Citations)
US5693043A
Cited
US4718417A
Cited
US4957114A
Cited
US4930516B1
Cited
US4930516A
Cited
US5042494A
Cited
US4768513A
Cited
US4927222A
Cited
US4847198A
Cited
US5131398A
Cited
US5687730A
Cited
US5261410A
Cited
US5280788A
Cited
US5507287A
Cited
US5348018A
Cited
US5467767A
Cited
US5452723A
Cited
US5439000A
Cited
US5601087A
Cited
US5705518A
Cited
US5786893A
Cited
US5413108A
Cited
US5784162A
Cited
US5556612A
Cited
US5590660A
Cited
US5778016A
Cited
US5456260A
Cited
US5522868A
Cited
US5701902A
Cited
US5697373A
Cited
US5615673A
Cited
US5699795A
Cited
US5738101A
Cited
US5647368A
Cited
US5769081A
Cited
US5753511A
Cited
US5751415A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-05-30 | 2003-11-29 | 2004-05-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-05-30 | 2007-11-29 | 2008-05-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-05-30 | 2011-11-29 | 2012-05-30 | $7700.00 | Window Closed / Lapsed |